FDA 483 - National Therapy Products Inc. - April 20, 2023

National Therapy Products Inc. in Brampton, Ontario, a medical device manufacturer, was cited for significant deficiencies during an FDA inspection. The inspection revealed issues with maintaining design history files, device master records for ultrasound gels, and proper documentation of corrective and preventive actions. These findings indicate a lack of adherence to quality system requirements for medical device manufacturing.